- $940.35m
- $3.49bn
- $2.73bn
Activist Jana Partners built position in QuidelOrtho in first quarter, sources say
Brief: QuidelOrtho Q1 EPS USD -25.5
Brief: QuidelOrtho Receives FDA 510(K) Clearance For Its QuickVue Covid-19 Test
Brief: QuidelOrtho Board Size Reduced From Eleven To Ten Directors
Brief: QuidelOrtho Announces Changes in Executive Leadership
Brief: Quidelortho Corp Sees 2024 Adjusted Diluted EPS $1.88 - $3.60 (Feb 13)
U.S. STOCKS ON THE MOVE-Citigroup, Lyft, Crypto stocks
QuidelOrtho Corp reports results for the quarter ended in December - Earnings Summary
Brief: QuidelOrtho Q4 EPS USD 0.1
QuidelOrtho Corp expected to post earnings of $2.05 a share - Earnings Preview
Brief: Quidelortho Receives 510(K) Clearance For Savanna® Multiplex Molecular Platform And Savanna® Hsv 1+2/Vzv Pcr Assay
Media: QuidelOrtho weighs sale of transfusion medicine unit- Bloomberg News
QuidelOrtho Corp reports results for the quarter ended in September - Earnings Summary
Brief: QuidelOrtho Q3 EPS USD -0.19
QuidelOrtho Corp expected to post earnings of 60 cents a share - Earnings Preview
Brief: Quidelortho Reports Preliminary Revenue Results For The Third Quarter 2023
Carlyle in exclusive talks for $7 bln-plus Medtronic units deal-sources
U.S. RESEARCH ROUNDUP-Intuit, Pioneer Natural Resources, Salesforce
Brief: Quidelortho Corp - Board Has Approved A Reduction In Size Of Board From 12 To 11 Members